Skip to main content
Equibles
NRIX logo

NRIX · Nurix Therapeutics, Inc. · Webcasts, Transcripts & Audio

Track NRIX — free

Use NRIX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NRIX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$22.84 +0.24 (+1.06%)
Russell 2000 member Rebalance outlook locked
Market Cap
$2.39B
Shares
103.78M
Volume · Oct 7 241.58K Avg daily vol (3M) 1.27M

Nurix Therapeutics, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Nurix Therapeutics, Inc. (NRIX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲61.2% $11.43M −$45.40M '22 Q2 22-07-07 ▼8.3% $6.78M −$46.72M '22 Q4 23-02-09 ▼60.6% $12.09M −$44.55M '24 Q2 24-07-11 ▼12.4% $13.28M −$58.55M '24 Q4 25-01-13 LATEST ▼79.5% $9.04M −$89.53M '26 Q2 26-06-08
Conference
Investor event
2026-09-16
Nurix Therapeutics, Inc. (NRIX) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-08
Nurix Therapeutics, Inc. (NRIX) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-06-08
Nurix Therapeutics, Inc. (NRIX) Q2 2026 Earnings Call
Revenue
$9.04M
▼ 79.5% YoY
Diluted EPS
$-0.81
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-03
Nurix Therapeutics, Inc. (NRIX) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-04-13
Nurix Therapeutics, Inc. (NRIX) April 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY24 · Q4
2025-01-13
Nurix Therapeutics, Inc. (NRIX) Q4 2024 Earnings Call
Revenue
$13.28M*
▼ 12.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q2
2024-07-11
Nurix Therapeutics, Inc. (NRIX) Q2 2024 Earnings Call
Revenue
$12.09M
▼ 60.6% YoY
Diluted EPS
$-0.71
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-09
Nurix Therapeutics, Inc. (NRIX) Q4 2022 Earnings Call
Revenue
$6.78M*
▼ 8.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q2
2022-07-07
Nurix Therapeutics, Inc. (NRIX) Q2 2022 Earnings Call
Revenue
$11.43M
▲ 61.2% YoY
Diluted EPS
$-1.01
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–9 of 9 webcasts
Key facts CIK 1549595 CUSIP 67080M103 13F (30d) 5 filings 5 filers Visit website Investor relations